Assessing medication consultations, hypertension control, awareness, and treatment among elderly asian community dwellers

Consultant Pharmacist

Volumn 23, Issue 10, 2008, Pages 795-803

  Lam, Annie Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Asian; Blood pressure; Community dwelling; Elderly; Hypertension; Medication consultation; Multiethnic; Older adults

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIAN; AWARENESS; BLOOD PRESSURE MEASUREMENT; CONSULTATION; COUGHING; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL EDEMA; PHARMACIST; RETROSPECTIVE STUDY; SELF REPORT; TREATMENT OUTCOME;

EID: 54249165488     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2008.795     Document Type: Article

References (24)

1. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Washington, DC: US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute; 2004. NIH Publication no. 04-5320:12.
2. American Heart Association. Statistical Update 2006. Dallas, TX: American Heart Association. Accessed April 16, 2008.
3. CDC National Center for Health Statistics National Health and Nutrition Survey. http://www.cdc.gov/nchs/nhanes.htm. Accessed July 1, 2007.
4. About the BRFSS. http://www.cdc.gov/brfss/about.htm. Accessed July 1, 2007.
5. Survey Questionnaires, Examination Components and Laboratory Components 2005-2006. http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_bpq_d.pdf. Accessed 7/1/2007.
6. Ong KL, Cheung BMY, Man YB et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007;49:69-75.
7. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
8. Li WW, Stewart AL, Stotts N et al. Cultural factors associated with antihypertensives medication adherence in Chinese immigrants. J Cardiovasc Nurs 2006;21:354-62.
9. Lau DS, Lee G, Wong CC et al. Characterization of systemic hypertension in the San Francisco Chinese community. Am J Cardiol 2005;96:570-3.
10. Duong DN, Ryan R, Vo DT et al. Hypertension screening and cardiovascular risk profiling in Vietnam. Nurs Health Sci 2003;5:269-73.
11. Chabot I, Moisan J, Gregorie JP et al. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003;37:1186-93.
12. Sookaneknun P, Richards R ME, Sanguansermsri J et al. Pharmacist involvement in primary care improves hypertensive patient clinical outcomes. Ann Pharmacother 2003;38:2023-8.
13. Zillich AJ, Sutherland JM, Kumbera PA et al. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med 2005;20:1091-6.
14. Chobanian AV, Bakris GL, Black HR et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
15. SHEP Cooperative Research Group. Prevention of stroke by antihypertensives drug treatment in older person with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
16. Curb JD, Pressel SL, Cutler JA et al. Effect of diuretic-based antihypertensives treatment on cardiovascular risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Group. JAMA 1997;276:1886-92.
17. Staessen JA, Fagard R, Thijs L et al. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997;350:757-64.
18. Liu L, Wang JG, Gong L et al. for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens 1998;16:1823-9.
19. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blockers vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
20. Liu L, Zhang Y, Liu W et al. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens 2005;23:2157-72.
21. Vasan RS, Larson MG, Leip EP et al. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-6.
22. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005;794:456-72.
23. Welch VLL, Hill MN. Effective strategies for BP control. Cardiol Clin 2002;20:321-33.
24. Scolaro KL, Stamm PL, Lloyd KB. Devices for ambulatory and home monitor of blood pressure. Lipids. Coagulation and weight management, part 1. Am J Health Syst Pharm 2005;62:1802-12.